Innovation drugs

JSC «Medvax» Ltd is a supplier of most indispensable drugs, as:
Avastin (Bevacizumab) (A humanized monoclonal antibody, a proven treatment for metastatic colorectal cancer, lung cancer, breast cancer)
Actemra (Tocilizumab)  (Innovative drug (a monoclonal antibody) for the treatment of rheumatoid arthritis)
Cotellic (Cobimetinib)
— Exjade (Deferasirox)
— Gazyva (Obinutuzumab)
Herceptin (Trastuzumab) (A treatment for breast cancer)
— Kadcyla (Trastuzumab)
— Mabthera (Rituximab)
— Ocrevus (Ocrelizumab)
— Perjeta (Pertuzumab)
— Revolade (Eltrombopag)
— Sandostatin LAR (Octreotide)
— Tasigna (Nilotinib)
— Tecentriq (atezolizumab)
— Zelboraf (Vemurafenib)